NEW YORK (360Dx) – Beckman Coulter said today that it has received US Food and Drug Administration 510(k) clearance for its Navios EX flow cytometer.

The Navios allows for simultaneous measurement of up to 12 parameters in individual cells. Beckman Coulter is launching the instrument at the American Association for Clinical Chemistry's annual meeting in San Diego this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.